arrow
M

Mario Poljak

university of ljubljana
H指数:63
被引数:1.6万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2)

甲基化标志物<i>FAM19A4/mir124-2</i>和HPV基因型在宫颈上皮内瘤变2级(CIN2)女性主动监测中的作用

2026-10-280
PRE
2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis

2022年WHO关于全球宫颈癌筛查覆盖率(包括总体覆盖率和基于人乳头瘤病毒检测的覆盖率)的估计:一项综述与综合分析

2026-10-140
OA
Emergence and spread of multirecombinant enterovirus A71 lineages C1.3/RF5 and C1.3/RF6 associated with neurological diseases in Europe, 2016–2022, ENPEN multicentre study

2016–2022年欧洲神经疾病相关的多重重组肠道病毒A71 C1.3/RF5和C1.3/RF6谱系的涌现与传播,ENPEN多中心研究

2026-08-080
OAAI
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening

国际合作研究:人乳头瘤病毒分析阈值在宫颈癌筛查中的敏感性和特异性

2026-04-250
OAAI
Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination Program

在实施国家HPV疫苗接种计划14年后,参加组织化国家宫颈癌筛查的斯洛文尼亚女性中高危人乳头瘤病毒(HPV)的流行率

2025-10-130
OAAI
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

用于宫颈癌筛查的新型HPV DNA检测验证的第二代比较试验标准

2024-09-022
OA
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance

人乳头瘤病毒阴性的高度宫颈病变和癌症: HPV检测质量保证的建议指南

2024-04-011
OAAI